유전자 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global genetic testing market size is expected to reach USD 106.00 Billion in 2034 from USD 16.84 Billion in 2025, growing at a CAGR of 22.68% during 2026-2034.The global genetic testing market is witnessing strong growth due to the increasing demand for personalized medicine and early disease detection. Genetic testing analyzes DNA to identify inherited conditions, genetic mutations, and potential health risks. These tests are widely used for diagnosing genetic disorders, cancer risk assessment, prenatal screening, and ancestry testing.

Advances in genomic technologies, particularly next-generation sequencing, have significantly improved the speed and accuracy of genetic testing. Healthcare providers are increasingly using genetic data to develop targeted treatment plans and predict disease susceptibility. The growing awareness of preventive healthcare and expanding access to genetic testing services are also contributing to market expansion.

In the future, the genetic testing market is expected to grow rapidly as precision medicine becomes more widely adopted. Increased investments in genomic research and declining sequencing costs will make genetic testing more accessible. As healthcare systems focus more on personalized treatments, genetic testing will become an essential component of modern medicine.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Technology

• Next Generation Sequencing
• Array Technology
• PCR-based Testing
• FISH
• Others

By Application

• Ancestry & Ethnicity
• Traits Screening
• Genetic Disease Carrier Status
• New Baby Screening
• Health and Wellness

By Product

• Consumables
• Equipment
• Software & Services

By Channel

• Online
• Offline

By End Use

• Hospitals & Clinics
• Diagnostic Laboratories
• Others

COMPANIES PROFILED

• 24Genetics, Circle DNA, Tellmegen, 23andMe, AncestryDNA, MyDNA, Everly Well, Igenomix, VitaGen, Myriad Genetics Inc., Mapmygenome, Helix OpCo LLC, MyHeritage Ltd., Illumina Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENETIC TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Next Generation Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Array Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. PCR-based Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. FISH Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENETIC TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Ancestry & Ethnicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Traits Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Genetic Disease Carrier Status Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENETIC TESTING MARKET: BY NEW BABY SCREENING 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast New Baby Screening
• 6.2. Health and Wellness Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENETIC TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Product
• 7.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENETIC TESTING MARKET: BY CHANNEL 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Channel
• 8.2. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Offline Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL GENETIC TESTING MARKET: BY END USE 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End Use
• 9.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL GENETIC TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Technology
  • 10.2.2 By Application
  • 10.2.3 By New Baby Screening
  • 10.2.4 By Product
  • 10.2.5 By Channel
  • 10.2.6 By End Use
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Technology
  • 10.3.2 By Application
  • 10.3.3 By New Baby Screening
  • 10.3.4 By Product
  • 10.3.5 By Channel
  • 10.3.6 By End Use
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Technology
  • 10.4.2 By Application
  • 10.4.3 By New Baby Screening
  • 10.4.4 By Product
  • 10.4.5 By Channel
  • 10.4.6 By End Use
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Technology
  • 10.5.2 By Application
  • 10.5.3 By New Baby Screening
  • 10.5.4 By Product
  • 10.5.5 By Channel
  • 10.5.6 By End Use
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Technology
  • 10.6.2 By Application
  • 10.6.3 By New Baby Screening
  • 10.6.4 By Product
  • 10.6.5 By Channel
  • 10.6.6 By End Use
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL GENETIC TESTING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 24Genetics
  • 12.2.2 Circle DNA
  • 12.2.3 Tellmegen
  • 12.2.4 23andMe
  • 12.2.5 AncestryDNA
  • 12.2.6 MyDNA
  • 12.2.7 Everly Well
  • 12.2.8 Igenomix
  • 12.2.9 VitaGen
  • 12.2.10 Myriad Genetics Inc
  • 12.2.11 Mapmygenome
  • 12.2.12 Helix OpCo LLC
  • 12.2.13 MyHeritage Ltd
  • 12.2.14 Illumina Inc